Continuing Education for Nurses and Social Workers
GOAL
To educate oncology nurses and social workers about diagnosis and treatment of peripheral T-cell lymphoma (PTCL)OBJECTIVES
At the conclusion of this program, participants should be able to:
- Explain PTCL and PTCL subtypes
- Describe treatment options for patients with newly diagnosed, refractory or relapsed PTCL
- Communicate the role of clinical trials as treatment options for patients with PTCL
- Discuss patient-provider communications about treatment options, including clinical trials
- Discuss patient-provider communications about side effects management
TARGET AUDIENCE
Oncology nurses and social workers involved in the treatment of PTCLCERTIFICATION
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number
CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.The Leukemia & Lymphoma Society (LLS), provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org Approved Continuing Education Program (ACE). Approval Period: December 2011 – December 2014. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 1.0 CE clinical clock hour.
Upon completion of this program and submission of the CE activity evaluation, a certificate of completion will be issued to you via email or US mail within 30 days.
SUPPORT STATEMENT
This program is supported by a grant from Celgene Corporation.